Griseofulvin Brown & Burk Uk

Griseofulvin Brown & Burk UK is an oral antifungal medication that contains the active ingredient griseofulvin. The product’s strength is not specified in the available data, and the dosage form is listed as unknown. It is marketed in the European Union and is available by prescription only. Griseofulvin works by inhibiting fungal cell division, making it useful for treating certain skin and hair fungal infections.

Griseofulvin Brown & Burk UK is indicated for the treatment of dermatophytic infections caused by susceptible fungi.

- Tinea corporis (ringworm of the body) - Tinea capitis (scalp ringworm) - Tinea pedis (athlete’s foot) - Tinea cruris (jock itch) - Other superficial dermatophytoses such as tinea barbae or tinea unguium when oral therapy is required

Side effects reported with oral griseofulvin vary in frequency and severity.

Common: - Headache, which may be mild to moderate in intensity. - Nausea, vomiting, or upset stomach that can affect appetite. - Skin rash or mild irritation, often transient. - Increased sensitivity to sunlight, leading to easy sunburn.

Serious: - Severe liver injury or hepatitis, presenting with jaundice or elevated enzymes. - Blood dyscrasias such as agranulocytosis or aplastic anemia, requiring immediate medical attention.

Before starting Griseofulvin Brown & Burk UK, certain precautions should be considered to minimize risks and ensure safe use.

- Assess liver function because griseofulvin is metabolized hepatically. - Review the patient’s complete blood count, especially if a history of hematologic disorders exists. - Use effective contraception; griseofulvin may reduce hormonal contraceptive efficacy. - Advise patients to avoid excessive sun exposure and to use sunscreen regularly. - Inform patients about the potential for drug interactions with CYP450 substrates. - Monitor for signs of allergic reaction during the first weeks of therapy. - Consider dose adjustment in patients with renal impairment if needed.

Griseofulvin can alter the metabolism of several medications, so awareness of potential interactions is important.

Avoid: - Oral contraceptives, as efficacy may be reduced. - Warfarin, due to possible increased anticoagulant effect. - Cyclosporine, because griseofulvin may raise cyclosporine levels.

Use with caution: - Antifungal agents such as itraconazole or ketoconazole, which share metabolic pathways. - Antiretroviral drugs metabolized by CYP3A4, e.g., protease inhibitors. - Certain antiepileptic drugs (e.g., phenytoin, carbamazepine) that may have altered levels.